Jan Emmerich

2.1k total citations
23 papers, 1.3k citations indexed

About

Jan Emmerich is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Jan Emmerich has authored 23 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Oncology, 10 papers in Immunology and 4 papers in Molecular Biology. Recurrent topics in Jan Emmerich's work include CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Sports Performance and Training (4 papers). Jan Emmerich is often cited by papers focused on CAR-T cell therapy research (7 papers), Immune Cell Function and Interaction (6 papers) and Sports Performance and Training (4 papers). Jan Emmerich collaborates with scholars based in United States, Germany and Austria. Jan Emmerich's co-authors include Ludger Klein, Martin Aichinger, Noboru Mizushima, Jelena Nedjic, Louise M. D’Cruz, Maria Hinterberger, Lee Kim Swee, Antonius Rolink, Elisabeth H. Vollmann and Martin Oft and has published in prestigious journals such as Nature, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Jan Emmerich

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jan Emmerich United States 11 818 291 265 247 119 23 1.3k
Adriana Karina Chávez-Rueda Mexico 20 1.1k 1.3× 185 0.6× 167 0.6× 255 1.0× 111 0.9× 53 1.7k
Igor Maricic United States 24 1.8k 2.2× 269 0.9× 299 1.1× 248 1.0× 168 1.4× 42 2.2k
Conor Mc Guire Belgium 15 677 0.8× 200 0.7× 136 0.5× 538 2.2× 133 1.1× 16 1.3k
Leigh A. Stephens United Kingdom 17 1.8k 2.2× 295 1.0× 125 0.5× 249 1.0× 443 3.7× 18 2.2k
Morteza Motallebnezhad Iran 19 382 0.5× 230 0.8× 111 0.4× 390 1.6× 66 0.6× 37 1.1k
Elisabeth H. Vollmann United States 8 742 0.9× 146 0.5× 55 0.2× 240 1.0× 76 0.6× 9 1.1k
Nadia Passini Italy 11 1.1k 1.3× 257 0.9× 127 0.5× 186 0.8× 100 0.8× 19 1.4k
Michael R. Daws Norway 20 1.1k 1.3× 195 0.7× 75 0.3× 460 1.9× 52 0.4× 29 1.6k
Shuang Fu China 15 582 0.7× 213 0.7× 60 0.2× 455 1.8× 116 1.0× 60 1.3k
Lianne van de Laar Netherlands 11 805 1.0× 187 0.6× 146 0.6× 387 1.6× 168 1.4× 14 1.3k

Countries citing papers authored by Jan Emmerich

Since Specialization
Citations

This map shows the geographic impact of Jan Emmerich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jan Emmerich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jan Emmerich more than expected).

Fields of papers citing papers by Jan Emmerich

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jan Emmerich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jan Emmerich. The network helps show where Jan Emmerich may publish in the future.

Co-authorship network of co-authors of Jan Emmerich

This figure shows the co-authorship network connecting the top 25 collaborators of Jan Emmerich. A scholar is included among the top collaborators of Jan Emmerich based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jan Emmerich. Jan Emmerich is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Oft, Martin, et al.. (2024). IL-2 based cancer immunotherapies: an evolving paradigm. Frontiers in Immunology. 15. 1433989–1433989. 23 indexed citations
2.
Oft, Martin, Navneet Ratti, Sandro Vivona, et al.. (2023). Abstract 1801: STK-012, an a/b-selective IL-2 activates tumor antigen specific CD25+ CD8 T cells to reject tumors without acute vascular toxicity. Cancer Research. 83(7_Supplement). 1801–1801. 1 indexed citations
4.
Aspuria, Paul‐Joseph, Sandro Vivona, Michele Bauer, et al.. (2021). An orthogonal IL-2 and IL-2Rβ system drives persistence and activation of CAR T cells and clearance of bulky lymphoma. Science Translational Medicine. 13(625). eabg7565–eabg7565. 61 indexed citations
5.
Emmerich, Jan, Michele Bauer, Bhargavi Jayaraman, et al.. (2021). Abstract 1744: STK-012, an alpha/beta selective IL-2 mutein for the activation of the antigen-activated T cells in solid tumor. Cancer Research. 81(13_Supplement). 1744–1744. 13 indexed citations
7.
Aspuria, Paul‐Joseph, Michael Bauer, Sandro Vivona, et al.. (2020). OrthoCARs: Engineered human IL-2/IL-2Rb orthogonal pairs selectively enhance CAR T cell antitumorefficacy. Blood. 136(Supplement 1). 35–35. 1 indexed citations
8.
10.
Emmerich, Jan, John B. Mumm, Ivan H. Chan, et al.. (2012). IL-10 Directly Activates and Expands Tumor-Resident CD8+ T Cells without De Novo Infiltration from Secondary Lymphoid Organs. Cancer Research. 72(14). 3570–3581. 228 indexed citations
11.
Emmerich, Jan, John B. Mumm, & Martin Oft. (2012). Autochthonous T cells to the rescue: IL-10 directly activates tumor-resident CD8+T cells. OncoImmunology. 1(9). 1637–1639. 6 indexed citations
12.
Nedjic, Jelena, Martin Aichinger, Jan Emmerich, Noboru Mizushima, & Ludger Klein. (2008). Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature. 455(7211). 396–400. 391 indexed citations
13.
D’Cruz, Louise M., Elisabeth H. Vollmann, Maria Hinterberger, et al.. (2007). Selection of Foxp3+ regulatory T cells specific for self antigen expressed and presented by Aire+ medullary thymic epithelial cells. Nature Immunology. 8(4). 351–358. 447 indexed citations
14.
Klein, Ludger, et al.. (2005). Selection and Behavior of CD4+ CD25+ T Cells In Vivo: Lessons from T Cell Receptor Transgenic Models. Current topics in microbiology and immunology. 293. 73–87. 8 indexed citations
15.
Emmerich, Jan, Claas A. Meyer, Aida Flor A. de la Cruz, Bruce A. Edgar, & Christian F. Lehner. (2004). Cyclin D Does Not Provide Essential Cdk4-Independent Functions in Drosophila. Genetics. 168(2). 867–875. 28 indexed citations
16.
17.
Arnaud, Emmanuelle, et al.. (1999). [Cytomegalovirus and arterial disease. Current aspects].. PubMed. 92(9). 1205–12. 4 indexed citations
18.
Emmerich, Jan & Fiessinger Jn. (1998). Epidémiologie et facteurs étiologiques des artérites à cellules géantes (maladie de Horton et maladie de Takayasu).. 149(7). 1 indexed citations
19.
Żołądź, Jerzy A., et al.. (1998). Pre-exercise acidification induced by ingestion of NH4Cl increases the magnitude of the slow component of VO2 kinetics in humans.. PubMed. 49(3). 443–55. 14 indexed citations
20.
Żołądź, Jerzy A., et al.. (1993). Changes in acid-base status of marathon runners during an incremental field test. European Journal of Applied Physiology. 67(1). 71–76. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026